DEVELOPING
 VITAL MEDICINES FOR 
THE TREATMENT AND PREVENTION
OF TROPICAL DISEASES


60° Pharmaceuticals (60P) was founded in 2010 with a mission to discover, develop, and distribute new medicines for the treatment and prevention of tropical diseases. Our core business is delivering tropical disease drug research and development while providing an attractive return to investors. 

60P has embraced an open innovation approach to reduce the time, cost, and risk needed to build a portfolio of drug discovery and development projects. We collaborate with leading research institutions in the United States, Australia, and Singapore to discover and develop medications for dengue and malaria prevention.


Investors



Learn more about
investing in 60P


Tropical Diseases



Innovative research into
tropical disease therapies



Malaria Program



Advancing therapies for
the treatment of malaria


 Learn More >
 Learn More >
 Read More >





About  |  Tropical Diseases  |  Products  |  Research   |  Investors  |  Media  |  Careers  |  Contact 

 1025 Connecticut Avenue NW, Suite 1000   Washington, DC 20036 
Phone: 1-240-351-1167   Email: inquiries@60degreespharma.com 

 Content © 2017. 60° Pharmaceuticals, LLC. All rights reserved.